Literature DB >> 29550935

Clinicopathologic risk factors for right paraesophageal lymph node metastasis in patients with papillary thyroid carcinoma.

Q A Yu1,2, D K Ma1, K P Liu1, P Wang3, C M Xie1, Y H Wu1, W J Dai4, H C Jiang5.   

Abstract

OBJECTIVES: To investigate risk factors associated with right paraesophageal lymph node (RPELN) metastasis in patients with papillary thyroid carcinoma (PTC) and to determine the indications for right lymph node dissection.
METHODS: Clinicopathologic data from 829 patients (104 men and 725 women) with PTC, operated on by the same thyroid surgery team at the First Affiliated Hospital of Harbin Medical University from January 2013 to May 2017, were analyzed. Overall, 309 patients underwent total thyroidectomy with bilateral lymph node dissection, 488 underwent right thyroid lobe and isthmic resection with right central compartment lymph node dissection, and 32 underwent near-total thyroidectomy (ipsilateral thyroid lobectomy with contralateral near-total lobectomy) with bilateral lymph node dissection.
RESULTS: The overall rate of central compartment lymph node metastasis was 43.5% (361/829), with right central compartment lymph node and RPELN metastasis rates of 35.5% (294/829) and 19.1% (158/829), respectively. Tumor size, number, invasion, and location, lymph node metastasis, right central compartment lymph node metastasis, and right lateral compartment lymph node metastasis were associated with RPELN in the univariate analysis, whereas age and sex were not. Multivariate analysis identified tumors with a diameter ≥ 1 cm, multiple tumors, tumors located in the right lobe, right central compartment lymph node metastasis, and right lateral compartment lymph node metastasis as independent risk factors for RPELN metastasis.
CONCLUSIONS: Lymph node dissection, including RPELN dissection, should be performed for patients with PTC with a tumor diameter ≥ 1 cm, multiple tumors, right-lobe tumors, right central compartment lymph node metastasis, or suspected lateral compartment lymph node metastasis.

Entities:  

Keywords:  Lymph node dissection; Metastasis; Papillary thyroid carcinoma (PTC); Right paraesophageal lymph node

Mesh:

Year:  2018        PMID: 29550935     DOI: 10.1007/s40618-018-0874-4

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  23 in total

1.  Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2011.

Authors:  Kyu-Won Jung; Young-Joo Won; Hyun-Joo Kong; Chang-Mo Oh; Duk Hyoung Lee; Jin Soo Lee
Journal:  Cancer Res Treat       Date:  2014-04-22       Impact factor: 4.679

Review 2.  Reappraisal of the indication for radioiodine thyroid ablation in differentiated thyroid cancer patients.

Authors:  M G Castagna; S Cantara; F Pacini
Journal:  J Endocrinol Invest       Date:  2016-06-27       Impact factor: 4.256

3.  Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer.

Authors:  David S Cooper; Gerard M Doherty; Bryan R Haugen; Bryan R Hauger; Richard T Kloos; Stephanie L Lee; Susan J Mandel; Ernest L Mazzaferri; Bryan McIver; Furio Pacini; Martin Schlumberger; Steven I Sherman; David L Steward; R Michael Tuttle
Journal:  Thyroid       Date:  2009-11       Impact factor: 6.568

4.  Tall cell and diffuse sclerosing variants of papillary thyroid cancer: outcome and predicting value of risk stratification methods.

Authors:  M Russo; P Malandrino; M Moleti; F Vermiglio; M A Violi; I Marturano; E Minaldi; R Vigneri; G Pellegriti; C Regalbuto
Journal:  J Endocrinol Invest       Date:  2017-05-20       Impact factor: 4.256

5.  Right paraesophageal lymph node dissection in papillary thyroid carcinoma.

Authors:  Soo Youn Bae; Jung-Hyun Yang; Min-Young Choi; Jun-Ho Choe; Jung-Han Kim; Jee Soo Kim
Journal:  Ann Surg Oncol       Date:  2011-11-18       Impact factor: 5.344

6.  Latero-cervical lymph node metastases (N1b) represent an additional risk factor for papillary thyroid cancer outcome.

Authors:  G Sapuppo; F Palermo; M Russo; M Tavarelli; R Masucci; S Squatrito; R Vigneri; G Pellegriti
Journal:  J Endocrinol Invest       Date:  2017-06-23       Impact factor: 4.256

7.  A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995 [see commetns].

Authors:  S A Hundahl; I D Fleming; A M Fremgen; H R Menck
Journal:  Cancer       Date:  1998-12-15       Impact factor: 6.860

8.  Metastasis of right upper para-esophageal lymph nodes in central compartment lymph node dissection of papillary thyroid cancer.

Authors:  Byung-Joo Lee; Jin-Choon Lee; Soo-Geun Wang; Yong-Ki Kim; In-Ju Kim; Seok-Man Son
Journal:  World J Surg       Date:  2009-10       Impact factor: 3.352

9.  Recommendations for post-surgical thyroid ablation in differentiated thyroid cancer: a 2015 position statement of the Italian Society of Endocrinology.

Authors:  F Pacini; E Brianzoni; C Durante; R Elisei; M Ferdeghini; L Fugazzola; S Mariotti; G Pellegriti
Journal:  J Endocrinol Invest       Date:  2015-08-12       Impact factor: 4.256

10.  Predictors of lymph nodes posterior to the right recurrent laryngeal nerve metastasis in patients with papillary thyroid carcinoma: A retrospective study.

Authors:  Jiru Yuan; Jinghua Li; Xiaoyi Chen; Zhenwei Zhong; Zhengbo Chen; Ying Yin; Jialin Du; Shuzhen Cong; Zeyu Wu
Journal:  Medicine (Baltimore)       Date:  2017-09       Impact factor: 1.889

View more
  8 in total

1.  High expression of SEZ6L2 as an independent prognostic Indicator in thyroid carcinoma.

Authors:  Xue Luo; Xinghong Chen; Song Chen; Qingjun Gao; Huifang Yang; Daiwei Zhao
Journal:  Gland Surg       Date:  2022-02

2.  Risk Factors for Predicting Lymph Nodes Posterior to Right Recurrent Laryngeal Nerve (LN-prRLN) Metastasis in Thyroid Papillary Carcinoma: A Meta-Analysis.

Authors:  Cunfu Li; Jun Xiang; Yunjun Wang
Journal:  Int J Endocrinol       Date:  2019-03-31       Impact factor: 3.257

3.  A meta-analysis of risk factors for lymph node posterior to the right recurrent laryngeal nerve metastasis in papillary thyroid carcinoma.

Authors:  Tianhan Zhou; Fan Wu; Lingqian Zhao; Kecheng Jiang; Dingcun Luo
Journal:  Gland Surg       Date:  2021-06

4.  Risk Factors for Lymph Node Metastasis in Papillary Thyroid Carcinoma: A Systematic Review and Meta-Analysis.

Authors:  Jingxin Mao; Qinghai Zhang; Haiyan Zhang; Ke Zheng; Rui Wang; Guoze Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2020-05-15       Impact factor: 5.555

5.  Value of dissection of lymph nodes posterior to the right recurrent laryngeal nerve in patients with cN0 papillary thyroid carcinoma.

Authors:  Xiangyuqin Xiao; Yaqin Wu; Lianhong Zou; Yiru Chen; Chaojie Zhang
Journal:  Gland Surg       Date:  2022-07

6.  Analysis of the Prognostic Value and Potential Molecular Mechanisms of TREM-1 Overexpression in Papillary Thyroid Cancer via Bioinformatics Methods.

Authors:  Zhenyu Xie; Xin Li; Yuzhen He; Song Wu; Shiyue Wang; Jianjian Sun; Yuchen He; Yu Lun; Shijie Xin; Jian Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-27       Impact factor: 5.555

7.  Immune-related key gene CLDN10 correlates with lymph node metastasis but predicts favorable prognosis in papillary thyroid carcinoma.

Authors:  Zhaolan Xiang; Cheng Zhong; Aoshuang Chang; Junjun Ling; Houyu Zhao; Wei Zhou; Xianlu Zhuo
Journal:  Aging (Albany NY)       Date:  2020-02-11       Impact factor: 5.682

8.  Metastasis of cN0 Papillary Thyroid Carcinoma of the Isthmus to the Lymph Node Posterior to the Right Recurrent Laryngeal Nerve.

Authors:  Wei Du; Qigen Fang; Xu Zhang; Liyuan Dai
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-10       Impact factor: 5.555

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.